Lucid Diagnostics Inc.
LUCD
$1.16
$0.021.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.40M | 4.36M | 4.17M | 4.35M | 4.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.40M | 4.36M | 4.17M | 4.35M | 4.19M |
| Cost of Revenue | 6.96M | 6.94M | 6.99M | 7.10M | 6.41M |
| Gross Profit | -2.56M | -2.58M | -2.82M | -2.75M | -2.22M |
| SG&A Expenses | 39.40M | 38.92M | 38.37M | 36.41M | 35.24M |
| Depreciation & Amortization | 418.00K | 418.00K | 418.00K | 587.00K | 994.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.31M | 52.20M | 51.82M | 50.30M | 49.32M |
| Operating Income | -47.91M | -47.84M | -47.65M | -45.95M | -45.13M |
| Income Before Tax | -53.29M | -55.26M | -61.83M | -45.53M | -44.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.29 | -55.26 | -61.83 | -45.53 | -44.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.29M | -55.26M | -61.83M | -45.53M | -44.82M |
| EBIT | -47.91M | -47.84M | -47.65M | -45.95M | -45.13M |
| EBITDA | -47.02M | -46.96M | -46.76M | -44.79M | -43.56M |
| EPS Basic | -0.90 | -1.05 | -1.20 | -1.07 | -1.13 |
| Normalized Basic EPS | -0.33 | -0.41 | -0.48 | -0.52 | -0.60 |
| EPS Diluted | -0.90 | -1.05 | -1.20 | -1.07 | -1.13 |
| Normalized Diluted EPS | -0.33 | -0.41 | -0.48 | -0.52 | -0.60 |
| Average Basic Shares Outstanding | 334.34M | 276.54M | 225.76M | 201.98M | 185.93M |
| Average Diluted Shares Outstanding | 334.34M | 276.54M | 225.76M | 201.98M | 185.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |